Trial Profile
The BOKITO-2B Study: Tenofovir DF Bone and Kidney Toxicity. Incidence and reversibility in HBV-monoinfected patients.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 12 Nov 2012
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Entecavir
- Indications Hepatitis B
- Focus Adverse reactions; Pharmacodynamics
- Acronyms BOKITO2B
- 12 Nov 2012 New trial record